Clinical trial

Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib

NCT01540526

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE1

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2019-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Malignanciesunresolved

Metastatic Castrate-resistant Prostate Cancerunresolved

Interventions

axitinibDRUG · verified · RxNorm: axitinib

Sponsors & collaborators

University of Wisconsin, Madisonlead sponsor

Pfizercollaborator

Mapped research locations

MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01540526 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.